Inventor
Shankar Kumar
Inventor
Pleasanton, CA, US
Overview
Patents· 26 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
C12NMicroorganisms or enzymes7%
A01HNew plants or non-transgenic processes for obtaining them4%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture4%
Y02ATechnologies for adaptation to climate change4%
PatentTitleYear
10,851,173Anti-OX40 antibodies and methods of using the same202010,202,461Anti-human TROP-2 antibody having an antitumor activity in vivo201910,196,450Anti-OX40 antibodies and methods of using the same201910,086,076Interleukin-13 binding proteins20189,695,246'Anti-OX40 antibodies and methods of using the same'20179,683,036'Humanized anti-IL-20 antibody and uses thereof'20179,592,293'Interleukin-13 binding proteins'20179,527,917'Nucleic acid encoding anti-OX40 antibodies'20169,427,464'Anti-human TROP-2 antibody having an antitumor activity in vivo'20169,303,086'Anti-hDlk-1 antibody having an antitumor activity in vivo'20169,163,085'Anti-OX40 antibodies and methods of treating cancer'20159,028,830'Antibodies to CD122'20159,006,399'Anti-OX40 antibodies and methods of using the same'20158,986,697'Antibodies for the treatment of Clostridium difficile-associated infection and disease'20158,821,863'Humanized anti-α 9 integrin antibodies and the uses thereof'20148,735,552'Generation, expression and characterization of the humanized K33N monoclonal antibody'20148,629,257'IL-12/p40 binding proteins'20148,617,829'Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof'20138,614,296'Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof'20138,604,177'Interleukin-13 binding proteins'20138,597,647'Humanized anti-IL-20 antibody and uses thereof'20138,017,118'Anti-hDlk-1 antibody having an antitumor activity in vivo'20117,915,388'Interleukin-13 binding proteins'20117,700,739'IL-12/p40 binding proteins'20107,442,777'Cytotoxicity mediation of cells evidencing surface expression of CD63'20087,223,393'Amphiregulin antibodies and their use to treat cancer and psoriasis'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007–2020Based in Pleasanton, CA, US· patent location history
2013–2015Patents assigned to KUMAR SHANKAR (11)· patent assignee history
2013–2015Patents assigned to TSURUSHITA NAOYA (9)· patent assignee history
2013–2015Patents assigned to TSO J YUN (7)· patent assignee history
2013–2018Patents assigned to ABBVIE INC (4)· patent assignee history
2013Based in Pleasonton, CA, US· patent location history
2015–2020Patents assigned to UNIV TEXAS (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| KUMAR SHANKARself | 11 | 2013–2015 |
| TSURUSHITA NAOYA | 9 | 2013–2015 |
| TSO J YUN | 7 | 2013–2015 |
| UNIV TEXAS | 6 | 2015–2020 |
| ABBVIE INC | 4 | 2013–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Pleasanton, California, US | 25 | 2007–2020 |
| Pleasonton, California, US | 1 | 2013 |